Feb 17, 2026 07:00AM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM
Jan 9, 2026 09:20AM
Jan 9, 2026 06:59AM
Jan 9, 2026 03:13AM
Jan 8, 2026 04:01PM Krystal Biotech reports gene therapy delivers CFTR protein to CF patients
Jan 8, 2026 04:01PM
Nov 3, 2025 07:00AM
Oct 17, 2025 05:50AM
Oct 14, 2025 08:03AM
Oct 14, 2025 08:00AM
Sep 16, 2025 06:53AM
Sep 15, 2025 02:20PM TD Cowen Reiterates Buy Rating on Krystal Biotech (KRYS)
Sep 15, 2025 08:00AM
Sep 15, 2025 08:00AM
Aug 22, 2025 07:57AM
Aug 22, 2025 06:53AM
Aug 21, 2025 12:14PM
Aug 21, 2025 12:11PM
Aug 4, 2025 07:00AM Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
Jul 25, 2025 09:01AM
Jul 25, 2025 09:00AM
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 9, 2025 07:04AM
Jul 9, 2025 07:00AM
Jun 24, 2025 07:00AM Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
Jun 3, 2025 08:00AM
May 7, 2025 08:00AM
May 6, 2025 08:00AM
Apr 28, 2025 07:05AM
Apr 28, 2025 07:00AM
Apr 24, 2025 08:00AM
Apr 17, 2025 08:00AM Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025
Apr 7, 2025 04:30PM
Apr 7, 2025 04:30PM
Feb 28, 2025 07:45AM
Feb 28, 2025 07:40AM
Feb 26, 2025 08:00AM
Feb 19, 2025 07:00AM
Feb 6, 2025 08:00AM Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
Jan 14, 2025 08:04AM
Jan 14, 2025 08:00AM
Dec 18, 2024 08:02AM
Dec 18, 2024 08:00AM
Dec 12, 2024 08:00AM
Dec 9, 2024 04:16PM
Dec 9, 2024 04:15PM Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
Nov 27, 2024 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All